Related Experiment Videos
Fosfomycin treatment of Haemophilus influenzae infection in mice
Abstract:
Haemophilus influenzae is an important pathogen in respiratory infections in children and often is implicated in otitis media. It is sensitive in vitro to a number of antibiotics, some of which are used clinically for the treatment of such infections. We have checked the in vitro sensitivity of a type b strain of H. influenzae. When tested in Levinthal's broth prepared with laked rabbit blood, the culture was most sensitive to tetracycline, ampicillin and penicillin and was somewhat less sensitive to cephalothin, fosfomycin, cephaloridine, and chloramphenicol. However, when this same strain was used to infect mice, fosfomycin was more active than ampicillin, tetracycline, chloramphenicol, penicillin or the cephalosporins.
Insights
This study compared antibiotic effectiveness against Haemophilus influenzae. Fosfomycin showed greater activity in vivo than ampicillin, penicillin, and tetracycline, despite differing in vitro sensitivity.
Area of Science:
- Microbiology
- Infectious Diseases
- Pharmacology
Background:
- Haemophilus influenzae is a significant cause of pediatric respiratory infections, including otitis media.
- Antibiotic sensitivity testing is crucial for guiding treatment decisions.
- Previous studies have established in vitro susceptibility patterns for H. influenzae.
Purpose of the Study:
- To evaluate the in vitro and in vivo efficacy of various antibiotics against a specific strain of Haemophilus influenzae type b.
- To compare the effectiveness of antibiotics in a laboratory setting versus a murine infection model.
Main Methods:
- In vitro antibiotic sensitivity testing of H. influenzae type b using Levinthal's broth with laked rabbit blood.
- Infection of mice with H. influenzae type b to assess in vivo antibiotic activity.
Main Results:
- In vitro, H. influenzae type b was most sensitive to tetracycline, ampicillin, and penicillin.
- In vitro, moderate sensitivity was observed for cephalothin, fosfomycin, cephaloridine, and chloramphenicol.
- In vivo, fosfomycin demonstrated superior activity compared to ampicillin, tetracycline, chloramphenicol, penicillin, and cephalosporins in infected mice.
Conclusions:
- Antibiotic effectiveness can differ significantly between in vitro sensitivity tests and in vivo infection models.
- Fosfomycin presents a promising therapeutic option for H. influenzae type b infections, warranting further investigation.
- Clinical treatment strategies should consider both in vitro data and in vivo efficacy for optimal outcomes.